secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001193125-25-142039
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.03, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q32 Bio stockholders approve officer exculpation charter amendment at 2025 annual meeting
--------------------------------------------------------------------------------

- Charter amendment limiting officer liability (Delaware law) approved; effective June 16, 2025.
- David Grayzel, Isaac Manke, and Diyong Xu elected Class I directors for three-year terms.
- Ernst & Young ratified as independent auditor for FY 2025 with 99.9% votes for.
- Say-on-pay advisory vote passed with 7.45M for; one-year frequency selected for future votes.
- Adjournment proposal also approved (7.88M for) but not needed as Proposal 2 passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312525142039/0001193125-25-142039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312525142039/d936533d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-142039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer